Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate

Details for Australian Patent Application No. 2011223697 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Blaugrund, Eran; Tarcic, Nora; Kaye, Joel

Agent FB Rice

Pub. Number AU-A-2011223697

PCT Pub. Number WO2011/109531

Priority 61/339,375 03.03.10 US

Filing date 2 March 2011

Wipo publication date 9 September 2011

International Classifications

A01N 43/42 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/109531 Priority application(s): WO2011/109531

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223702-Treatment of lupus arthritis using laquinimod

2011223694-Bio-based in-line high barrier metalized film and process for its production